3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myeloid, Acute
53
Precursor Cell Lymphoblastic Leukemia-Lymphoma
16
Burkitt Lymphoma
10
Leukemia
9
Myelodysplastic Syndromes
7
Leukemia, Biphenotypic, Acute
6
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
5
Myeloproliferative Disorders
5
Down Syndrome
3
Sarcoma, Myeloid
2
Lymphoma
2
Leukemia, Monocytic, Acute
2
Hematologic Neoplasms
2
Thrombocythemia, Essential
1
Recurrence
1
Primary Myelofibrosis
1
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
1
Polycythemia Vera
1
Philadelphia Chromosome
1
Neoplasms
1
Neoplasm, Residual
1
Lymphoma, T-Cell
1
Leukemia, Myelomonocytic, Juvenile
1
Leukemia, Myelomonocytic, Chronic
1
Leukemia, Myelomonocytic, Acute
1
Leukemia, Basophilic, Acute
1
Acute Myeloid Leukemia With KMT2A Rearrangement
1
Interventions
fludarabine
5
Cyclophosphamide
5
fludarabine phosphate
4
Whole-Body Irradiation
2
Tacrolimus
2
Peripheral Blood Stem Cell Transplantation
2
Patient Reported Outcome Measures
2
Mycophenolic Acid
2
Mesna
2
Melphalan
2
Busulfan
2
Bendamustine Hydrochloride
2
AP 1903 reagent
2
pembrolizumab
1
isatuximab
1
ibrutinib
1
Lenalidomide
1
Dexamethasone
1
CLR1404
1
CA-4948
1
Bortezomib
1
Bone Marrow Transplantation
1
ARQ531
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Immunoproliferative Disorders
×
Daunorubicin
×
1 year
×
Clear all
No trials found.